| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
3 companies
Broadwood Partners, L.P. is a Director, 10% Owner at LCTX with holdings across 3 companies. Recent SEC Form 4 filings include 60 buys and 0 sells.
Estimated insider holdings value: $543.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 570,184 | $3.56 | $2,032,251.45 | +0.8% | - | - | |
| Apr 20, 2026 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 182,861 | $3.57 | $652,875.63 | +0.3% | - | - | |
| Jan 9, 2026 | STAA Staar Surgical Co | 10% Owner | Buy | 27,485 | $22.05 | $606,137.70 | - | +14.0% | - | |
| Jan 8, 2026 | STAA Staar Surgical Co | 10% Owner | Buy | 406,653 | $21.68 | $8,817,663.72 | +0.3% | -7.2% | - | |
| Nov 21, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 1,500,000 | $27.37 | $41,060,317.11 | +1.8% | -36.1% | - | |
| Apr 10, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 187,227 | $15.31 | $2,866,428.46 | +0.2% | +10.1% | +69.8% | |
| Apr 7, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 845,220 | $16.12 | $13,627,504.30 | +0.6% | +2.9% | +30.7% | |
| Apr 2, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 53,969 | $17.44 | $941,285.43 | +0.1% | -3.3% | +14.8% | |
| Mar 28, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 113,384 | $17.50 | $1,983,823.65 | +0.2% | -5.4% | +0.6% | |
| Mar 25, 2025 | STAA Staar Surgical Co | 10% Owner | Buy | 136,696 | $17.66 | $2,414,722.39 | +0.3% | -4.5% | +9.9% |